摘要
目的对184例原发性和转移性肝癌行氩氦靶向治疗,探讨其近期局部治疗效果、不良反应及并发症。方法局部麻醉,在B超或CT监视下,经皮穿刺靶向治疗。结果 184例中97例治疗时间在1年以上,1年生存率70.1％(68/97)。术后并发肝内出血4例(2.2％),肝区疼痛64例(34.8％),发热92例(50.0％)。结论 经皮氩氦靶向治疗肝癌是一种效果好、并发症少、安全可靠的局部治疗肝癌方法。
Objective To investigate the local efficacy, adverse reaction and complication of 184 patients with hepatocellular carcinoma and metastasis treated with Ar-He target cryoablation. Method Using local anesthesia, under B-ultrasonography or computer tomography monitoring, 184 ptatients were treated with percutaneous Ar-He target cryoablation. Results Of the 184 patients,97 were followed up for longer than 12 months. The one-year survival rate was 70.1%(68 cases) . Complications were intrahepatic hemorrhage in 4 cases(2.2% ),liver pain in 64 cases(34.8%)and fever in 92 cases(50.0% ). Conclusion Percutaneous Ar-He target cryoablation was the effective, safe and reliable method for treatment of liver cancer.
出处
《中国肿瘤临床与康复》
2004年第2期138-141,共4页
Chinese Journal of Clinical Oncology and Rehabilitation
